Advertisement
Screener

STREAMEX CORP. (STEX) Increase (Decrease) in Prepaid Expense and Other Assets

STREAMEX CORP. Increase (Decrease) in Prepaid Expense and Other Assets

STREAMEX CORP. (STEX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $70.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-19.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2025-05-19

  • STREAMEX CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was $70.00K, a 438.46% increase year-over-year.
  • STREAMEX CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-12-31 was -$33.00K.
  • STREAMEX CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-09-30 was -$51.00K, a 183.61% decline year-over-year.
  • STREAMEX CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-06-30 was -$55.00K, a 113.32% decline year-over-year.
  • STREAMEX CORP. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$126.00K.
  • STREAMEX CORP. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$118.00K.
  • STREAMEX CORP. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$30.00K.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month
2025-03-31$70.00K
10-Q · filed 2025-05-19
$37.00K
derived: sum of 2 quarters · filed 2025-05-19
-$14.00K
derived: sum of 3 quarters · filed 2025-05-19
-$69.00K
derived: sum of 4 quarters · filed 2025-05-19
2024-12-31-$33.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-$84.00K
derived: sum of 2 quarters · filed 2025-04-15
-$139.00K
derived: sum of 3 quarters · filed 2025-04-15
-$126.00K
10-K · filed 2025-04-15
2024-09-30-$51.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$106.00K
derived: sum of 2 quarters · filed 2024-11-14
-$93.00K
10-Q · filed 2024-11-14
-$836.00K
derived: sum of 4 quarters · filed 2025-05-19
2024-06-30-$55.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$42.00K
10-Q · filed 2024-08-14
-$785.00K
derived: sum of 3 quarters · filed 2025-05-19
-$724.00K
derived: sum of 4 quarters · filed 2025-05-19
2024-03-31$13.00K
10-Q · filed 2025-05-19
-$730.00K
derived: sum of 2 quarters · filed 2025-05-19
-$669.00K
derived: sum of 3 quarters · filed 2025-05-19
-$256.00K
derived: sum of 4 quarters · filed 2025-05-19
2023-12-31-$743.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-$682.00K
derived: sum of 2 quarters · filed 2025-04-15
-$269.00K
derived: sum of 3 quarters · filed 2025-04-15
-$118.00K
10-K · filed 2025-04-15
2023-09-30$61.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$474.00K
derived: sum of 2 quarters · filed 2024-11-14
$625.00K
10-Q · filed 2024-11-14
$491.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$413.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$564.00K
10-Q · filed 2024-08-14
$430.00K
derived: sum of 3 quarters · filed 2024-08-14
2023-03-31$151.00K
10-Q · filed 2024-05-20
$17.00K
derived: sum of 2 quarters · filed 2024-05-20
2022-12-31-$134.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
-$30.00K
10-K · filed 2024-04-16
2022-09-30$104.00K
10-Q · filed 2023-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B